
Core Insights - Recursion, a clinical stage TechBio company, is set to provide business updates and Q2 2024 financial results on August 8, 2024, before market opening [1] - The company will host a public earnings call on the same day, allowing audience interaction and questions [1] Company Overview - Recursion specializes in decoding biology to industrialize drug discovery, utilizing its proprietary Recursion OS platform [1] - The platform integrates diverse technologies and maintains one of the largest biological and chemical datasets globally [1] - Recursion employs advanced machine-learning algorithms to identify trillions of relationships in biology and chemistry, free from human bias [1] - The company conducts millions of wet lab experiments weekly and operates one of the world's most powerful supercomputers [1] - Recursion is headquartered in Salt Lake City and is a founding member of BioHive, a collective for Utah's life sciences industry [1]